These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 28686393)

  • 41. Transmission of macrolide-resistant Mycoplasma pneumoniae within a family.
    Miyashita N; Kawai Y; Akaike H; Teranishi H; Ouchi K; Okimoto N
    J Infect Chemother; 2013 Dec; 19(6):1196-201. PubMed ID: 23624834
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Life-threatening pneumonia caused by macrolide-resistant Mycoplasma pneumoniae.
    Hsieh YC; Tsao KC; Huang CG; Tong S; Winchell JM; Huang YC; Shia SH; Lai SH; Lin TY
    Pediatr Infect Dis J; 2012 Feb; 31(2):208-9. PubMed ID: 21941216
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Mycoplasma pneumoniae and Legionella pneumophila in community-acquired lower respiratory tract infections among hospitalized children: diagnosis by real time PCR.
    Maltezou HC; La-Scola B; Astra H; Constantopoulou I; Vlahou V; Kafetzis DA; Constantopoulos AG; Raoult D
    Scand J Infect Dis; 2004; 36(9):639-42. PubMed ID: 15370649
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Emerging role of Mycoplasma pneumoniae and Chlamydia pneumoniae in paediatric respiratory-tract infections.
    Principi N; Esposito S
    Lancet Infect Dis; 2001 Dec; 1(5):334-44. PubMed ID: 11871806
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Prevalence of Mycoplasma pneumoniae: a cause for community-acquired infection among pediatric populaztion.
    Chen FQ; Yang YZ; Yu LL; Bi CB
    Niger J Clin Pract; 2015; 18(3):354-8. PubMed ID: 25772918
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Macrolide-Resistant Mycoplasma pneumoniae Infections in Pediatric Community-Acquired Pneumonia.
    Chen YC; Hsu WY; Chang TH
    Emerg Infect Dis; 2020 Jul; 26(7):1382-1391. PubMed ID: 32568052
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Mycoplasma and Chlamydia pneumonia in pediatrics.
    Nelson CT
    Semin Respir Infect; 2002 Mar; 17(1):10-4. PubMed ID: 11891514
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Outbreak of community-acquired pneumonia caused by Mycoplasma pneumoniae--Colorado, 2000.
    Can Commun Dis Rep; 2001 Jun; 27(12):104-7. PubMed ID: 11420988
    [No Abstract]   [Full Text] [Related]  

  • 49. Mycoplasma pneumoniae causes over 50% of community-acquired pneumonia in school-aged children.
    Korppi M; Heiskanen-Kosma T; Kleemola M
    Scand J Infect Dis; 2003; 35(4):294. PubMed ID: 12839167
    [No Abstract]   [Full Text] [Related]  

  • 50. Community-acquired pneumonia caused by macrolide-resistant Mycoplasma pneumoniae in adults.
    Hanada S; Morozumi M; Takahashi Y; Mochizuki S; Sato T; Suzuki S; Uruga H; Takaya H; Miyamoto A; Morokawa N; Ubukata K; Kishi K
    Intern Med; 2014; 53(15):1675-8. PubMed ID: 25088885
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Viral and Mycoplasma pneumoniae community-acquired pneumonia and novel clinical outcome evaluation in ambulatory adult patients in China.
    Cao B; Ren LL; Zhao F; Gonzalez R; Song SF; Bai L; Yin YD; Zhang YY; Liu YM; Guo P; Zhang JZ; Wang JW; Wang C
    Eur J Clin Microbiol Infect Dis; 2010 Nov; 29(11):1443-8. PubMed ID: 20623362
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Rapid effectiveness of minocycline or doxycycline against macrolide-resistant Mycoplasma pneumoniae infection in a 2011 outbreak among Japanese children.
    Okada T; Morozumi M; Tajima T; Hasegawa M; Sakata H; Ohnari S; Chiba N; Iwata S; Ubukata K
    Clin Infect Dis; 2012 Dec; 55(12):1642-9. PubMed ID: 22972867
    [TBL] [Abstract][Full Text] [Related]  

  • 53. From the Centers for Disease Control and Prevention. Outbreak of community-acquired pneumonia caused by Mycoplasma pneumoniae--Colorado, 2000.
    JAMA; 2001 Apr; 285(16):2073-4. PubMed ID: 11347553
    [No Abstract]   [Full Text] [Related]  

  • 54. Rapid detection of Mycoplasma pneumoniae and its macrolide-resistance mutation by Cycleave PCR.
    Liu Y; Ye X; Zhang H; Wu Z; Xu X
    Diagn Microbiol Infect Dis; 2014 Apr; 78(4):333-7. PubMed ID: 24503503
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Prevalence of Mycoplasma pneumoniae Infection in Malagasy Children.
    Ravelomanana L; Bouazza N; Rakotomahefa M; Andrianirina AZ; Robinson AL; Raobidjaona H; Andriamihaja R; Benhaddou N; Randrianirina F; Ratsima E; Imbert P; Raymond J
    Pediatr Infect Dis J; 2017 May; 36(5):467-471. PubMed ID: 28403048
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Role of Mycoplasma pneumoniae and Chlamydia pneumoniae in children with community-acquired lower respiratory tract infections.
    Principi N; Esposito S; Blasi F; Allegra L;
    Clin Infect Dis; 2001 May; 32(9):1281-9. PubMed ID: 11303262
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Characteristics of Mycoplasma pneumoniae infection identified on culture in a pediatric clinic.
    Katsushima Y; Katsushima F; Suzuki Y; Seto J; Mizuta K; Nishimura H; Matsuzaki Y
    Pediatr Int; 2015 Apr; 57(2):247-52. PubMed ID: 25265270
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Mycoplasma pneumoniae infection in hospitalized adult patients with community-acquired pneumonia in China.
    Shangguan Z; Sun Q; Zhang M; Ding J; Yi L; Gao Y; Zhan A; Zhao R; Ci X
    J Infect Dev Ctries; 2014 Oct; 8(10):1259-66. PubMed ID: 25313601
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Macrolide-Resistant Mycoplasma pneumoniae, United States.
    Zheng X; Lee S; Selvarangan R; Qin X; Tang YW; Stiles J; Hong T; Todd K; Ratliff AE; Crabb DM; Xiao L; Atkinson TP; Waites KB
    Emerg Infect Dis; 2015 Aug; 21(8):1470-2. PubMed ID: 26196107
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Servere atypical pneumonia with macrolide-resistant Mycoplasma pneumoniae].
    Bruno Pedersen AS; Østergaard L; Jespersen S
    Ugeskr Laeger; 2018 Jul; 180(30):. PubMed ID: 30037385
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.